🏅 FDA Orphan Designation

Humate-P

Antihemophilic factor/von Willebrand factor complex (human), dried, pasteurized

Manufacturer: CSL Behring

Indicated for:

Pseudo-von Willebrand diseaseOrphanHemophilia AVon Willebrand disease

FDA-Approved Indications (3)

Pseudo-von Willebrand diseaseOrphan Designation

Hemophilia A

treatment and prevention of bleeding in hemophilia A (classic hemophilia)

Population: adults

Von Willebrand disease

treatment of spontaneous and trauma-induced bleeding episodes in severe von Willebrand disease, and in mild and moderate von Willebrand disease where use of desmopressin is known or suspected to be in…

Population: adult and pediatric

Indications & Usage

(1) In adult patients for treatment and prevention of bleeding in hemophilia A (classic hemophilia) and (2) in adult and pediatric patients for treatment of spontaneous and trauma-induced bleeding episodes in severe von Willebrand disease, and in mild and moderate von Willebrand disease where use of desmopressin is known or suspected to be inadequate.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.